Coty Prepares Lancaster and Orveda for China’s Predicted Skincare Revival

Coty’s CEO, Sue Nabi, addressed the firm’s performance and future outlook in the 2024 earnings conference. Despite anticipating continued short-term negative growth in China’s skincare market, Nabi emphasized China’s importance for Coty’s long-term strategy, as it is expected to be one of the largest beauty markets. Currently, Coty’s business in China is small, contributing about 3% of the company’s fiscal 2024 revenues, but this has sheltered it from the current market pressures.

Coty is preparing for a future skincare market resurgence in China, starting with its Lancaster brand, which has seen impressive growth and market share gains. Lancaster’s success is credited to a focus on sun protection and photo-ageing, appealing strongly to Chinese consumers. Nabi plans to strengthen Coty’s skincare portfolio in China further, involving brands such as Lancaster and Orveda.

Meanwhile, Coty has experienced robust growth in the fragrance sector, particularly in prestige fragrances with brands like Burberry, Chloe, and Calvin Klein performing well. The company is redirecting investments to capitalize on growth opportunities in China’s fragrance market.